Cortexyme Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cortexyme Inc
TickerQNCX
CIK #0001662774
CUSIP22053A107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address269 East Grand Ave, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2025
[0001662774] 10-K
[0001662774] 10-Q
[0001662774] 3
[0001662774] 4
[0001662774] 5
[0001662774] 8-K
[0001662774] D
[0001662774] SC 13D
[0001662774] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Nantahala Capital Management LLC Quince Therapeutics Inc [2025-08-14] 0.0
Sofinnova Partners SAS Quince Therapeutics Inc [2025-02-14] 0.0
Lamond David Quince Therapeutics Inc [2024-11-13] 819410.1
Sofinnova Partners SAS Quince Therapeutics Inc [2024-02-12] 5.1
Genextra Spa Quince Therapeutics Inc [2023-12-15] 5.89
BML Investment Partners LP Quince Therapeutics Inc [2023-07-17] 4.04
Tang Capital Partners LP Quince Therapeutics Inc [2023-03-31] 9.98
Capital World Investors Cortexyme Inc [2021-02-16] 8.8
Capital International Investors Cortexyme Inc [2021-02-16] 8.7
Capital International Investors Cortexyme Inc [2021-02-16] 8.7
Lamond David Cortexyme Inc [2019-09-30] 7.17
Lamond Pierre Cortexyme Inc [2019-09-30] 10.75
EPQ LLC CTYM PS Cortexyme Inc [2019-06-10] 3.51
Pfizer Inc Cortexyme Inc [2019-05-22] 12.2
Takeda Pharmaceutical Co Ltd Cortexyme Inc [2019-05-20] 0.9
Form 3/4/5 Filer 2011 - 2025
Hannah Brendan
Quince Therapeutics, Inc.
Ryan Charles S.
Thye Dirk
Lamond David
Senner Christopher J.
Benatti Luca
Ryan UNA S
Patni Rajiv
Bray June
McLoughlin Margaret
Janhofer Guenter
Monohon Ted
Smith Karen L.
McDowell Caryn Gordon
Holsinger Leslie
Low Philip S
Sabbagh Marwan
Detke Michael J.
Lowe Christopher P
Dominy Stephen S.
Lynch Casey
Boeding Chad
EPIQ Capital Group, LLC
Young Kevin
Pfizer Inc
Pfizer Strategic Investment Holdings LLC
Pfizer Ventures (US) LLC
Gafric Kristen
Takeda Ventures, Inc.
Takeda Pharmaceuticals International AG
Takeda Pharmaceutical Co Ltd
Takeda Pharmaceuticals U.S.A., Inc.
Lamond Pierre
Lamond Christine
Form 13F Holdings
Firm Period DFND Voting Shares
Nantahala Capital Management LLC [2025-06-30] SOLE 2,528,302 2,528,302
Vanguard Group Inc [2025-06-30] SOLE 0 1,447,877
IEQ Capital LLC [2025-06-30] SOLE 0 439,270
Geode Capital Management LLC [2025-06-30] DFND 396,982 396,982
Renaissance Technologies LLC [2025-06-30] SOLE 379,800 379,800
Rockefeller Capital Management L.P. [2025-06-30] DFND 339,108 339,108
BlackRock, Inc. [2025-06-30] SOLE 335,738 335,738
Hightower Advisors LLC [2025-06-30] SOLE 308,500 308,500
Alphabet Inc. [2025-06-30] DFND 0 189,122
Shay Capital LLC [2025-06-30] SOLE 150,000 150,000
Adar1 Capital Management LLC [2025-06-30] SOLE 142,958 142,958
Bridgeway Capital Management LLC [2025-06-30] SOLE 128,617 128,617
State Street Corp [2025-06-30] DFND 124,911 124,911
Mariner LLC [2025-06-30] SOLE 0 122,461
Union Square Park Capital Management LLC [2025-06-30] SOLE 120,857 120,857
Millennium Management LLC [2025-06-30] SOLE 110,682 110,682
Citadel Advisors LLC [2025-06-30] DFND 93,905 93,905
Scharf Investments LLC [2025-06-30] SOLE 0 91,061
Northern Trust Corp [2025-06-30] DFND 77,492 77,492
Intellectus Partners LLC [2025-06-30] SOLE 53,312 53,312
GSA Capital Partners LLP [2025-06-30] SOLE 33,818 33,818
Anfield Capital Management LLC [2025-06-30] DFND 0 30,227
XTX Topco Ltd [2025-06-30] DFND 22,660 22,660
Two Sigma Investments LP [2025-06-30] SOLE 17,386 17,386
Cambridge Investment Research Advisors Inc [2025-06-30] SOLE 0 15,200
Wolverine Trading LLC [2025-06-30] DFND 0 12,800
Two Sigma Securities LLC [2025-06-30] SOLE 12,004 12,004
Nixon Peabody Trust Co [2025-06-30] SOLE 11,126 11,126
Wells Fargo & Company/MN [2025-06-30] DFND 0 6,990
Vanguard Group Inc [2025-06-30] DFND 0 6,161
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com